Lin Chen
7Patents
1h-index
22Co-inventors
47Inventor score
Filing activity: Aug 27, 2009 → Nov 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10106502B2 | Direct inhibitors of Keap1-Nrf2 interaction as antioxidant inflammation modulators | Physics | 2 | Active |
| US9109040B2 | Treatment and prevention of malaria | Emerging Cross-Sectional Technologies | 1 | Active |
| US9884101B2 | Treatment and prevention of malaria | Emerging Cross-Sectional Technologies | 1 | Active |
| US11446345B2 | Therapeutic agents and uses thereof for drugs for treatment of tumors and/or cancers | Chemistry; Metallurgy | 0 | Active |
| US11806374B2 | Isolated recombinant oncolytic adenoviruses, pharmaceutical compositions, and uses thereof for drugs for treatment of tumors and/or cancers | Chemistry; Metallurgy | 0 | Active |
| US9134311B2 | Methods and compositions for treating and preventing malaria using an invasion ligand directed to a protease-resistant receptor | Emerging Cross-Sectional Technologies | 0 | Active |
| US12193407B2 | Single factor modeling-constraint method and device for mice chronic fatigue syndrome | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.